8-99135674-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017890.5(VPS13B):c.1504C>T(p.Arg502*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017890.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Cohen syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VPS13B | NM_017890.5 | c.1504C>T | p.Arg502* | stop_gained | Exon 11 of 62 | ENST00000358544.7 | NP_060360.3 | |
| VPS13B | NM_152564.5 | c.1504C>T | p.Arg502* | stop_gained | Exon 11 of 62 | ENST00000357162.7 | NP_689777.3 | |
| VPS13B | NM_015243.3 | c.1504C>T | p.Arg502* | stop_gained | Exon 11 of 18 | NP_056058.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VPS13B | ENST00000358544.7 | c.1504C>T | p.Arg502* | stop_gained | Exon 11 of 62 | 1 | NM_017890.5 | ENSP00000351346.2 | ||
| VPS13B | ENST00000357162.7 | c.1504C>T | p.Arg502* | stop_gained | Exon 11 of 62 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151968Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251170 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461226Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726922 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74220 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cohen syndrome Pathogenic:4
This sequence change creates a premature translational stop signal (p.Arg502*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant is present in population databases (rs180177354, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Cohen syndrome (PMID: 15154116, 16648375). ClinVar contains an entry for this variant (Variation ID: 68083). For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: VPS13B c.1504C>T (p.Arg502X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.4411C>T (p.Arg1471X), c.7603C>T (p.Arg2535X), c.8515C>T (p.Arg2839X)). The variant allele was found at a frequency of 1.2e-05 in 251320 control chromosomes (gnomAD and Hennies_2004) and has been reported in the literature in individuals affected with Cohen Syndrome (example Hennies_2004, Seifert_2006, Tsangaris_2011). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has a submitted clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
The observed stop gained c.1504C>Tp.Arg502Ter variant in VPS13B gene has been reported previously in individuals affected with Cohen syndrome Tsangaris E, et al., 2011; Hennies HC, et al., 2004. The c.1504C>T variant is present with 0.001% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Likely Pathogenic / Pathogenic. Computational evidence MutationTaster - Disease causing predicts damaging effect on protein structure and function for this variant. The nucleotide change c.1504C>T in VPS13B is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal p.Arg502Ter in the VPS13B gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants in VPS13B gene have been previously reported to be disease causing Parri V, et al., 2010. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at